Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Analysis: U.S. Economic Data Shows Little Sign of Weakness, Fed Unlikely to Cut Rates This Week

Analysis: U.S. Economic Data Shows Little Sign of Weakness, Fed Unlikely to Cut Rates This Week

ChaincatcherChaincatcher2025/05/05 15:01
Show original

According to Jinshi reports, Julius Baer economist David Kohl stated that the U.S. economy shows almost no signs of weakness. After the release of the April non-farm payroll report, he said: "The unstable and restrictive economic policies of the United States, including the introduction of high tariffs, have so far not had the expected negative impact on labor market data." The economist pointed out that better-than-expected job additions and low unemployment rates have driven continued strong growth in private consumption.

Kohl added that the data is very solid, and it is expected that the Federal Reserve will not cut interest rates this week. Kohl said the Federal Reserve might ignore the negative data from survey indicators and wait to act until economic data shows weakness.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ-Pacira BioSciences stock surges on Viatris' $1.65 billion acquisition deal

On October 8, Pacira BioSciences (PCRX.O) shares rose 44% in pre-market trading to $36.30 as Viatris (VTRS.O) announced it will acquire Pacira BioSciences for $1.65 billion in cash, at a price of $36.50 per share. This offer represents a premium of approximately 44.8% over Pacira's last closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris’ product portfolio. Both parties expect the deal to be completed by the end of 2026. As of the previous trading day’s close, PCRX was down 2.6% year-to-date.

路透社•2026/10/08 12:31

BUZZ - Devon Energy shares rise after the company agrees to sell Eagle Ford assets for $4.2 billions

October 8 - Oil and gas producer Devon Energy (DVN.N) rose 2.65% in pre-market trading to $49.15. The company announced it would sell its Eagle Ford assets to Crescent Energy (CRGY.N) for $4.2 billions in cash. Devon's Eagle Ford assets include approximately 90,000 net acres in Texas, representing about 4% of its total oil equivalent production. This asset divestiture comes as the company, following its merger with Coterra Energy, faces investor pressure to streamline its asset portfolio and focus on its core Permian Basin business. The transaction is expected to be completed around the end of 2026. CRGY shares fell 2% to $13.20; the company also announced a $1 billions stock offering to raise funds for the DVN transaction. As of the previous trading day’s close, DVN shares had surged 30.71% year-to-date.

路透社•2026/10/08 12:26

Kepler Weber executives trim stake by R$ 24,461.40 via on-market sales

Kepler Weber disclosed two cash equity sales by management totaling 3,788 shares for R$ 24,461.40 at an average R$ 6.45674. Transactions were executed via XP, with sales on day 1 at R$ 6.55 and day 16 at R$ 6.41. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kepler Weber SA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/08 12:23

BUZZ - Universal Display shares fall after Citi downgraded rating

On October 8, shares of OLED materials company Universal Display (OLED.O) fell by 4.5% in pre-market trading to $73.8. Citigroup downgraded Universal Display from “Neutral” to “Sell” and lowered its price target from $85 to $71. The new target price implies about an 8% downside from the previous closing price. The brokerage pointed out the continued weakness in the smartphone market and delays in the adoption of blue OLED technology. Citigroup also noted that high memory costs and weak demand for mid- and low-end smartphones may continue to drag down sales of OLED materials. Out of 10 brokerages, seven rate the stock as “Buy” or higher, and three rate it as “Hold.” The median price target is $117.5. As of the previous trading day's close, the stock had fallen a cumulative 33.88% so far this year.

路透社•2026/10/08 12:06